PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr | ₹427 Cr |
What is the latest Cash Flow from Operating Activities ratio of PFIZER ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹660 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹356 Cr |
| Mar2022 | ₹667 Cr |
| Mar2021 | ₹427 Cr |
How is Cash Flow from Operating Activities of PFIZER Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹660 Cr | 156.87 | |
| Mar2024 | ₹257 Cr | -27.79 | |
| Mar2023 | ₹356 Cr | -46.68 | |
| Mar2022 | ₹667 Cr | 56.10 | |
| Mar2021 | ₹427 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,449.1 Cr | 3.8% | -4.4% | 4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 3.8% |
-4.4% |
4.4% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses